Immunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infection

Mucosal Immunology

Volumn 1, Issue 1, 2008, Pages 78-88

  Zhu, Q ^a   Thomson, C W ^a   Rosenthal, K L ^a   McDermott, M R ^a   Collins, S M ^b   Gauldie, J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD8 ANTIGEN; DENDRITIC CELL VACCINE; HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN A; MEDROXYPROGESTERONE ACETATE; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; DRUG POTENCY; FEMALE; GENE EXPRESSION; GENETIC IMMUNIZATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA; LAMINA PROPRIA; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VACCINIA; VAGINA MUCOSA; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 48649092597     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2007.3     Document Type: Article

References (80)

1. Pitman, R.S. & Blumberg, R.S. First line of defense: The role of the intestinal epithelium as an active component of the mucosal immune system. J. Gastroenterol. 35, 805-814 (2000).
2. MacDonald, T.T. & Monteleone, G. Immunity, inflammation, and allergy in the gut. Science 307, 1920-1925 (2005).
3. Lamm, M.E. Interaction of antigens and antibodies at mucosal surfaces. Annu. Rev. Microbiol. 51, 311-340 (1997).
4. Harty, J.T, Tvinnereim, A.R. & White, D.W. CD8+ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18 275-308 (2000).
5. Oxenius, A., Price, D.A., Trkola, A., Edwards, C., Gostick, E., Zhang, H.T. et al. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies. J. Infect Dis. 190, 713-721 (2004).
6. McDermott, M.R., Brais, L.J. & Evelegh, M.J. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol. 71 (Part 7), 1497-1504 (1990).
7. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. & Kiyono, H. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 10, 75-88 (1992).
8. Lehner, T, Bergmejer, L., Wang, Y., Tao, L. & Mitchell, E. A rational basis for mucosal vaccination against HIV infection. Immunol. Rev. 170, 183-196 (1999).
9. Belyakov, I.M., Derby, M.A., Ahlers, J.D., Kelsall, B.L., Earl, P., Moss, B. et al. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge, Proc. Natl. Acad. Sci. USA 95, 1709-1714 (1998).
10. Kozlowski, P.A., Cu-Uvin, S., Neutra, M.R. & Flanigan, T.P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun. 65, 1387-1394 (1997).
11. Kantele, A., Hakkinen, M., Moldoveanu, Z., Lu, A., Savilahti, E., Alvarez, R. D. et al. Differences in immune responses induced by orol and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun. 66, 5630-5635 (1998).
12. Eriksson, K., Quiding-Jarbrink, M., Osek, J., Moller, A., Bjork, S., Holmgren, J. et al. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect. Immun. 66, 5889-5896 (1998).
13. Shen, X., Lagergard, T., Yang, Y., Lindblad, M., Fredriksson, M. & Holmgren, J. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine. Infect. Immun. 68, 5749-5755 (2000).
14. Gallichan, W.S. & Rosenthal, K.L. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J. Infect. Dis. 177, 1155-1161 (1998).
15. Vajdy, M., Gardner, J., Neidleman, J., Cuadra, L, Greer, C., Perri, S. et al. Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles. J. Infect. Dis. 184, 1613-1616 (2001).
16. MacPherson, G.G. & Liu, L.M. Dendritic cells and Langerhans cells in the uptake of mucosal antigens. Curr. Top. Microbiol. Immunol. 236 33-53 (1999).
17. Iwasaki, A. & Kelsall, B.L. Mucosal immunity and inflammation. I. Mucosal dendritic cells: Their specialized role in initiating T cell responses. Am. J. Physiol. 276 (5 Part 1), G1074-G1078 (1999).
18. Karrer, U., Althage, A., Odermatt, B., Roberts, C.W., Korsmeyer, S.J., Miyawak, S. et al. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice. J. Exp. Med. 185, 2157-2170 (1997).
19. Belyakov, I.M. & Berzofsky, J.A. Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 20, 247-253 (2004).
20. Graham, F.L. Adenoviruses as expression vectors and recombinant vaccines. Trends Biotechnol. 8, 85-87 (1990).
21. Wilson, J.M. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1187 (1996).
22. Hogaboam, C.M., Vallance, B.A., Kumar, A., Addison, C.L., Graham, F.L., Gauldie, J. et al. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J. Clin. Invest. 100, 2766-2776 (1997).
23. Wirtz, S., Galle, P.R. & Neurath, M.F. Efficient gone delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure. Gut 44, 800-807 (1999).
24. Lindsay, J.O., Ciesielski, C.J., Scheinin, T., Brennan, F.M. & Hodgson, H.J. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis. Gut 52, 363-369 (2003).
25. Kagi, D., Ledermann, B., Burki, K., Zinkemagel, R.M. & Hengartner, H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232 (1996).
26. Russell, J. H. & Ley, T.J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20, 323-370 (2002).
27. Guidotti, L.G. & Chisari, F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65-91 (2001).
28. Wu, Q., Xia, D., Carlsen, S. & Xiang, J. Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancer. Curr. Gene Ther. 5, 237-247 (2005).
29. Van Ginkel, F.W., Liu, C., Simecka, J.W., Dong, J.Y., Greenway, T., Frizzell, R.A. et al. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase. Hum. Gene Ther. 6, 895-903 (1995).
30. Holmberg, S.D., Stewart, J.A., Gerber, A.R., Byers, R.H., Lee, F.K., O'Malley, P.M. et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 259, 1048-1050 (1988).
31. Chen, C.Y., Ballard, R.C., Beck-Sague, C.M., Dangor, Y., Radebe, F., Schmid, S. et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: The herpetic connection. Sex Transm. Dis. 27, 21-29 (2000).
32. Renzi, C., Douglas, J.M Jr, Foster, M., Critchlow, C.W., Ashley-Morrow, R., Buchbinder, S.P. et al. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J. Infect. Dis. 187, 19-25 (2003).
33. Owen, W.F. Jr Sexually transmitted diseases and traumatic problems in homosexual men. Ann. Intern. Med. 92, 805-808 (1980).
34. Wexner, S.D. Sexually transmitted diseases of the colon, rectum, and anus. The challenge of the nineties. Dis. Colon. Rectum. 33, 1048-1062 (1990).
35. Mayer, L. & Shlien, R. Evidence for function of la molecules on gut epithelial cells in man. J. Exp. Med. 166, 1471-1483 (1987).
36. Hershberg, R.M., Cho, D.H., Youakim, A., Bradley, M.B., Lee, J.S., Framson, P.E. et al. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J. Clin. Invest. 102, 792-803 (1998).
37. Komuro, T Fenestrations of the basal lamina of intestinal villi of the rat. Scanning and transmission electron microscopy. Cell Tissue Res. 239, 183-188 (1985).
38. Hashimoto, Y. & Komuro, T. Close relationships between the cells of the immune system and the epithelial cells in the rat small irrtestine. Cell Tissue Res. 254, 41-47 (1988).
39. Bell, S.J., Rigby, R., English, N., Mann, S.D., Knight, S.C., Kamm, M.A. et al. Migration and maturation of human colonic dendritic cells. J. Immunol. 166, 4958-4967 (2001).
40. Zinkemagel, R.M. & Hengartner, H. Regulation of the immune response by antigen. Science 293, 251-253 (2001).
41. Gallichan, W.S., Johnson, D.C., Graham, F.L. & Rosenthal, K.L. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 168, 622-629 (1993).
42. Parr, M.B. & Parr, E.L. Vaginal immunity in the HSV-2 mouse model. Int. Rev. Immunol. 22, 43-63 (2003).
43. Kwant, A. & Rosenthal, K.L. Intravaginal immunization withviral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2. Vaccine 22, 3098-3104 (2004).
44. Gallichan, W.S. & Rosenthal, K.L. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13, 1589-1595 (1995).
45. Wu, H.Y., Abdu, S., Stinson, D. & Russell, M.W. Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect. Immun. 68, 5539-5545 (2000).
46. Bergmeier, L.A., Tao, L., Gearing, A.J., Adams, S. & Lehner, T. Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue. Adv. Exp. Med. Biol. 371B, 1567-1573 (1995).
47. Gallichan, W.S. & Rosenthal, K.L. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J. Exp. Med. 184, 1879-1890 (1996).
48. Brandtzaeg, R, Farstad, I.N. & Haraldsen, G. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track. Immunol. Today 20, 267-277 (1999).
49. Lehner, T. Innate and adaptive mucosal immunity in protection against HIV infection. Vaccine 21 (Suppl 2), S68-S76 (2003).
50. Moldoveanu, Z., Vzorov, A.N., Huang, W.Q., Mestecky, J. & Compans, R.W. Induction of immune responses to SIV antigens by mucosally administered vaccines. AIDS Res. Hum. Retroviruses 15, 1469-1476 (1999).
51. McCluskie, M.J., Brazolot Millen, C.L., Gramzinski, R.A., Robinson, H.L., Santoro, J.C., Fuller, J.T. et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol. Med. 5, 287-300 (1999).
52. McCluskie, M.J. & Davis, H.L. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19, 413-422 (2000).
53. Neutra, M.R. & Kozlowski, P.A. Mucosal vaccines: The promise and the challenge. Nat Rev. Immunol. 6, 148-158 (2006).
54. Harvey, B.G., Maroni, J., O'Donoghue, K.A., Chu, K.W., Muscat, J.C., Pippo, A. L. et al. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum. Gene Ther. 13, 15-63 (2002).
55. Crystal, R.G., Harvey, B.G., Wisnivesky, J.P., O'Donoghue, K.A., Chu, K.W., Maroni, J. et al. Analysis of risk factors for local delivery ol low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum. Gene Ther. 13, 65-100 (2002).
56. Grydsuk, J.D., Fortsas, E., Petric, M. & Brown, M. Common epitope on protein VI of enteric adenoviruses from subgenera A and F. J. Gen. Virol. 77 (Part 8), 1811-1819 (1996).
57. Croyle, M.A., Stone, M., Amidon, G.L. & Roessler, B.J. In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther. 5, 645-654 (1998).
58. Jobin, C., Panja, A., Hellerbrand, C., Iimuro, Y., Didonato, J., Brenner, D.A. et al. Inhibition of proinflammatory molecule production by adenovirus- mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J. Immunol. 160, 410-418 (1998).
59. Gomez-Roman, V. R. & Robert-Guroff, M. Adenoviruses as vectors for HIV vaccines. AIDS Rev. 5, 178-185 (2003).
60. Casimiro, D.R., Bett, A.J., Fu, T.M., Davies, M.E., Tang, A., Wilson, K.A. et al. Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors. J. Virol. 78, 11434-11438 (2004).
61. Rea, D., Schagen, F.H., Hoeben, R.C., Mehtali, M., Havenga, M.J., Toes, R.E. et al. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J. Virol. 73, 10245-10253 (1999).
62. Lundqvist, A., Choudhury, A., Nagata, T., Andersson, T., Quinn, G., Fong, T. et al. Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis. Hum. Gene Ther. 13, 1541-1549(2002).
63. Jenne, L., Hauser, C., Arrighi, J.F., Saurat, J.H. & Hugin, A.W. Poxvirus as a vector to transduce human dendritic cells for immunotherapy: Abortive infection but reduced APC function. Gene Ther. 7, 1575-1583 (2000).
64. Engelmayer, J., Larsson, M,, Subklewe, M., Chahroudi, A., Cox, W.I., Steinman, R.M. et al. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion. J. Immunol. 163, 6762-6768(1999).
65. Drillien, R., Spehner, D. & Hanau, D. Modified vaccinia virus Ankara induces moderate activation of human dendritic cells. J. Gen. Virol. 85 (Part 8), 2167-2175 (2004).
66. Wright, P.F., Mestecky, J., McElrath, M.J., Keefer, M.C., Gorse, G.J., Goopfert, P.A. et al. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J. Infect. Dis. 189, 1221-1231 (2004).
67. Goepfert, P.A., Horton, H., McElrath, M.J., Gurunathan, S., Ferran, G., Tomaras, G.D. et al. High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. J. Infect. Dis. 192, 1249-1259 (2005).
68. Woogen, S.D., Ealding, W. & Elson, C.O. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin. J. Immunol. 139, 3764-3770(1987).
69. Elson, C.O., Holland, S.F., Dertzbaugh, M.T, Cuff, C.F. & Anderson, A.O. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immunol. 154, 1032-1040 (1995).
70. Nashar, T.O., Williams, N.A. & Hirst, T.R. Cross-linking of cell surface ganglioside GM1 induces the selective apoptosis of mature CD8+ T lymphocytes. Int. Immunol. 8, 731-736 (1996).
71. Fraser, S.A., de, H.L., Hearn, A.R., Bone, H.K., Salmond, R.J., Rivett, A.J. et al. Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions. Infect. Immun. 71, 1527-1537 (2003).
72. Floochi In Immunology and immunopathology of the liver and gastrointestinal tract (Targan, S.T., & Shanahan, F. eds). (IGAKU-SHOIN Medical Publishers: New York, 1990).
73. Gorczynski, R.M., Cohen, Z., Levy, G. & Fu, X. M. A role for gamma(delta)TCR+ cells in regulation of rejection of small intestinal allografts in rats. Transplantation 62, 844-851 (1996).
74. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figad, I.S., Bradley, A. & Stewart, T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739-1742 (1993).
75. Wan, Y., Emtage, P., Zhu, Q., Foley, R., Pilon, A., Roberts, B. et al. Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells. Cell Immunol. 198, 131-138 (1999).
76. Gallichan, W.S. & Rosenthal, K.L. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology 224, 487-497 (1996).
77. Hitt, M., Bett, A., Prevec, F.L. & Graham, F.L. Construction and propagation of human adenovirus vectors in Cell Biology: A Laboratory Handbook (Cells JE ed) 500-512 (San Diego: Academic Press, 1998).
78. Addison, C.L., Hitt, M., Kunsken, D. & Graham, F.L. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol. 78 (Part 7), 1653-1661 (1997).
79. McHugh, K.J., Weingarten, H.P., Keenan, C., Wallace, J.L. & Collins, S.M. On the suppression of food intake in experimental models of colitis in the rat. Am. J. Physiol. 264 (5 Part 2), R871-R876 (1993).
80. Parr, E.L. & Parr, M.B. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 71, 8109-8115 (1997).